Rothia mucilaginosa Infections in Pediatric Cancer Patients | Zendy

Rachel B Getzenberg | Zendy; Diego R. Hijano | Zendy; Hana Hakim | Zendy; Ronald H. Dallas | Zendy; Jose Ferrolino | Zendy; Jessica N Brazelton | Zendy; Cherilyn D. Garner | Zendy; Li Tang | Zendy; Yin Su | Zendy; Joshua Wolf | Zendy; Randall T. Hayden | Zendy; Gabriela Marón | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rothia mucilaginosa Infections in Pediatric Cancer Patients

Author(s) -

Rachel B Getzenberg,

Diego R. Hijano,

Hana Hakim,

Ronald H. Dallas,

Jose Ferrolino,

Jessica N Brazelton,

Cherilyn D. Garner,

Li Tang,

Yin Su,

Joshua Wolf,

Randall T. Hayden,

Gabriela Marón

Publication year - 2020

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piaa047

Subject(s) - medicine , pediatric cancer , cancer , epidemiology , vancomycin , retrospective cohort study , intensive care medicine , gram positive bacterial infections , pediatrics , antibiotics , microbiology and biotechnology , staphylococcus aureus , biology , bacteria , genetics

We performed a retrospective study to determine the epidemiology of Rothia mucilaginosa infections among pediatric cancer patients. Over 20 years, 37 cases were identified; 27% developed complications, but there was no infection-related mortality. All cases were successfully treated with vancomycin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research